Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine for PCA after thoracoscopic surgery
ChiCTR2100045298Phase 4Recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Numerical Pain Score. Started Apr 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100045298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045298.